tbi-1401
Biologicalexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jun 1, 2015 (NCT02428036)
Timeline
2010s
- Jan 1, 2015
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- tbi-1401
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03252808 | Phase 1 | Sep 25, 2017 | Otsuka, Takara Bio Inc. |
| NCT02428036 | Phase 1 | Jun 1, 2015 | Takara Bio Inc. |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Takara Bio Inc. | For profit | 2 | 2 | 1 | 2015 |
| Otsuka | For profit | 1 | 0 | 1 | 2017 |
2 organizations
Page 1 / 1